Data sets of human and mouse protein kinase inhibitors with curated activity data including covalent inhibitors.

IF 2.4 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Future Science OA Pub Date : 2023-08-16 eCollection Date: 2023-10-01 DOI:10.2144/fsoa-2023-0088
Elena Xerxa, Jürgen Bajorath
{"title":"Data sets of human and mouse protein kinase inhibitors with curated activity data including covalent inhibitors.","authors":"Elena Xerxa,&nbsp;Jürgen Bajorath","doi":"10.2144/fsoa-2023-0088","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>Generation of high-quality data sets of protein kinase inhibitors (PKIs).</p><p><strong>Methodology: </strong>Publicly available PKIs with reliable activity data were curated. PKIs with very weak activity were classified as inactive. Analogue series and PKIs containing reactive groups (warheads) enabling covalent inhibition were systematically identified.</p><p><strong>Exemplary results & data: </strong>A total of 155,579 human and 3057 mouse PKIs were obtained. Human PKIs were active 440 kinases and included 13,949 covalent PKIs. The collection of qualifying PKIs and corresponding inactive compounds is made available as an open access deposition.</p><p><strong>Limitations & next steps: </strong>Potential limitations include activity data incompleteness and assay variance. The data set can be used to investigate PKIs with alternative modes of action and calibrate computational methods.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"9 9","pages":"FSO892"},"PeriodicalIF":2.4000,"publicationDate":"2023-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518807/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future Science OA","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2144/fsoa-2023-0088","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/10/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: Generation of high-quality data sets of protein kinase inhibitors (PKIs).

Methodology: Publicly available PKIs with reliable activity data were curated. PKIs with very weak activity were classified as inactive. Analogue series and PKIs containing reactive groups (warheads) enabling covalent inhibition were systematically identified.

Exemplary results & data: A total of 155,579 human and 3057 mouse PKIs were obtained. Human PKIs were active 440 kinases and included 13,949 covalent PKIs. The collection of qualifying PKIs and corresponding inactive compounds is made available as an open access deposition.

Limitations & next steps: Potential limitations include activity data incompleteness and assay variance. The data set can be used to investigate PKIs with alternative modes of action and calibrate computational methods.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
具有精确活性数据的人和小鼠蛋白激酶抑制剂的数据集,包括共价抑制剂。
目的:生成高质量的蛋白激酶抑制剂(PKIs)数据集。方法:筛选具有可靠活性数据的公开可用的PKIs。具有非常弱活性的PKI被归类为非活性。系统地鉴定了能够进行共价抑制的含有反应基团(弹头)的类似物系列和PKI。示例性结果和数据:共获得155579个人类和3057个小鼠PKI。人PKIs是440种活性激酶,包括13949种共价PKIs。合格的PKI和相应的非活性化合物的集合可作为开放式沉积提供。限制和下一步:潜在的限制包括活动数据的不完整性和分析方差。该数据集可用于研究具有替代作用模式的PKI并校准计算方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Future Science OA
Future Science OA MEDICINE, RESEARCH & EXPERIMENTAL-
CiteScore
5.00
自引率
4.00%
发文量
48
审稿时长
13 weeks
期刊介绍: Future Science OA is an online, open access, peer-reviewed title from the Future Science Group. The journal covers research and discussion related to advances in biotechnology, medicine and health. The journal embraces the importance of publishing all good-quality research with the potential to further the progress of research in these fields. All original research articles will be considered that are within the journal''s scope, and have been conducted with scientific rigour and research integrity. The journal also features review articles, editorials and perspectives, providing readers with a leading source of commentary and analysis. Submissions of the following article types will be considered: -Research articles -Preliminary communications -Short communications -Methodologies -Trial design articles -Trial results (including early-phase and negative studies) -Reviews -Perspectives -Commentaries
期刊最新文献
Case report: lichen planus in a patient with ulcerative colitis receiving sulfasalazine: a drug effect or a disease manifestation? Validation of salivary proteomic biomarkers for early detection of oral cancer in the Egyptian population. Endoscope disinfectant-induced colonic pseudolipomatosis: case series of a rare condition. A comprehensive approach for detection of biotin deficiency from dried blood spot samples using liquid chromatography-mass spectrometry. Ferric carboxymaltose for iron deficiency in patients with heart failure: a systematic review and meta-analysis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1